Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).
Status:
Completed
Trial end date:
2019-11-13
Target enrollment:
Participant gender:
Summary
This study is a national, multicenter, interventional, non-randomized, non-controlled,
open-label study to assess the effectiveness of pirfenidone in participants with IPF in
Russian clinical practice.